R. Wilder

发表

Hormonal Regulation of Tumor Necrosis Factor‐α, Interleukin‐12 and Interleukin‐10 Production by Activated Macrophages: A Disease‐modifying Mechanism in Rheumatoid Arthritis and Systemic Lupus Erythematosus?

I. Elenkov, R. Wilder, 1999, Annals of the New York Academy of Sciences.

Dark Agouti and Fischer 344 rats: differential behavioral responses to morphine and biochemical differences in the ventral tegmental area

E. Nestler, E. Remmers, G. Heninger, 1999, Neuroscience.

Hormones, Pregnancy, and Autoimmune Diseases

R. Wilder, 1998, Annals of the New York Academy of Sciences.

Decline of atrial natriuretic peptide release in dogs during sustained rapid cardiac pacing.

S. Lightman, R. Sutton, T. Williams, 1988, Clinical science.

Susceptibility to Autoimmune Disease and Drug Addiction in Inbred Rats: Are There Mechanistic Factors in Common Related to Abnormalities in Hypothalamic‐Pituitary‐Adrenal Axis and Stress Response Function?

E. Remmers, R. Caspi, G. Cannon, 2000, Annals of the New York Academy of Sciences.

A Defect in the Central Component of the Immune System‐ Hypothalamic‐Pituitary‐Adrenal Axis Feedback Loop Is Associated with Susceptibility to Experimental Arthritis and Other Inflammatory Diseases

E. Sternberg, P. Gold, G. Chrousos, 1990, Annals of the New York Academy of Sciences.

Glucocorticoid Therapy for Immune-Mediated Diseases: Basic and Clinical Correlates

D. Boumpas, J. Balow, T. Cupps, 1993, Annals of Internal Medicine.

Local Expression of Corticotropin‐Releasing Hormone in Inflammatory Arthritis

L. Crofford, K. Karalis, T. Friedman, 1995, Annals of the New York Academy of Sciences.

Neuroimmunoendocrinology of the Rheumatic Diseases

Ronald L. Wilder, R. Wilder, 2002 .

Inhibition by Cyclosporin A of Streptococcal Cell Wall‐induced Hepatic Granulomas in LEW/N Rats

S. Wahl, D. Yocum, R. Wilder, 1986, Annals of the New York Academy of Sciences.

Transforming Growth Factor‐β in Rheumatoid Arthritis

M. Sporn, J. Case, A. Roberts, 1990 .

Neuroendocrine Regulation of IL‐12 and TNF‐α/IL‐10 Balance: Clinical Implications

I. Elenkov, R. Wilder, G. Chrousos, 2000 .

Reduction of plasma prolactin by acute administration of CB-154 in ovariectomized F344 and Holtzman rats treated with diethylstilbestrol: a comparison of RIA and Nb2 lymphoma bioassay.

D. Lawson, N. Jackson, R. Wilder, 1993, Life sciences.

The Stress Response and the Regulation of Inflammatory Disease

G. Chrousos, E. Sternberg, P. Gold, 1992, Annals of Internal Medicine.

Inferior petrosal sinus sampling in healthy subjects reveals a unilateral corticotropin-releasing hormone-induced arginine vasopressin release associated with ipsilateral adrenocorticotropin secretion.

J. Doppman, G. Chrousos, L. Nieman, 1996, The Journal of clinical investigation.

Hypothalamic-pituitary-adrenal axis perturbations in patients with fibromyalgia.

S. Pillemer, G. Chrousos, L. Crofford, 1994, Arthritis and rheumatism.

Neuroendocrine-immune system interactions and autoimmunity.

R L Wilder, R. Wilder, R. Wilder, 1995, Annual review of immunology.

The sympathetic nerve--an integrative interface between two supersystems: the brain and the immune system.

G. Chrousos, E. Vizi, I. Elenkov, 2000, Pharmacological reviews.

A central nervous system defect in biosynthesis of corticotropin-releasing hormone is associated with susceptibility to streptococcal cell wall-induced arthritis in Lewis rats.

G. Chrousos, W. Young, E. Sternberg, 1989, Proceedings of the National Academy of Sciences of the United States of America.

Inflammatory mediator-induced hypothalamic-pituitary-adrenal axis activation is defective in streptococcal cell wall arthritis-susceptible Lewis rats.

G. Chrousos, E. Sternberg, P. Gold, 1989, Proceedings of the National Academy of Sciences of the United States of America.

Modulatory effects of glucocorticoids and catecholamines on human interleukin-12 and interleukin-10 production: clinical implications.

D. Papanicolaou, G. Chrousos, I. Elenkov, 1996, Proceedings of the Association of American Physicians.

Circadian relationships between interleukin (IL)-6 and hypothalamic-pituitary-adrenal axis hormones: failure of IL-6 to cause sustained hypercortisolism in patients with early untreated rheumatoid arthritis.

G. Chrousos, L. Crofford, P. Gold, 1997, The Journal of clinical endocrinology and metabolism.

Autocrine or paracrine inflammatory actions of corticotropin-releasing hormone in vivo.

G. Chrousos, K. Karalis, S. Listwak, 1991, Science.

Corticotropin-releasing hormone in synovial fluids and tissues of patients with rheumatoid arthritis and osteoarthritis.

E. Remmers, G. Chrousos, L. Crofford, 1993, Journal of immunology.

Local secretion of corticotropin-releasing hormone in the joints of Lewis rats with inflammatory arthritis.

G. Chrousos, L. Crofford, K. Karalis, 1992, The Journal of clinical investigation.

IL-12, TNF-alpha, and hormonal changes during late pregnancy and early postpartum: implications for autoimmune disease activity during these times.

G. Chrousos, I. Elenkov, M. Dimitrov, 2001, The Journal of clinical endocrinology and metabolism.

Histamine potently suppresses human IL-12 and stimulates IL-10 production via H2 receptors.

D. Papanicolaou, G. Chrousos, T. Fleisher, 1998, Journal of immunology.

Responses of the sympathetic nervous system and the hypothalamic-pituitary-adrenal axis to interleukin-6: a pilot study in fibromyalgia.

D. Papanicolaou, S. Pillemer, G. Chrousos, 2000, Arthritis and rheumatism.

Exercise stimulates interleukin-6 secretion: inhibition by glucocorticoids and correlation with catecholamines.

D. Papanicolaou, C. Tsigos, G. Chrousos, 1996, The American journal of physiology.

Local secretion of corticotropin-releasing hormone by enterochromaffin cells in human colon.

G. Chrousos, M. Kondo, M. Kawata, 1994, Gastroenterology.

Glucocorticoid Therapy for Immune-Mediated Diseases: Basic and Clinical Correlates

D. Boumpas, J. Balow, T. Cupps, 1993, Annals of Internal Medicine.